US$ 29.50
glp 1 drug coverage GLP-1s and The Payer Predicament Costly GLP-1 Drugs are Rarely
Description
It is the primary ingredient in Citrucel

10.3389/fphar.2020.589114

Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis

Additionally, individuals with a BMI of 27 or higher who have weight-related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol may also benefit from these injections

National Research Council
